Literature DB >> 18570208

Is severe macrosomia manifested at 11-14 weeks of gestation?

R Hackmon1, K B Le Scale, J Horani, A Ferber, M Y Divon.   

Abstract

OBJECTIVE: To determine the association between fetal biometry in the first or early second trimester and severe macrosomia at delivery.
METHODS: This case-control study included 30 term severely macrosomic neonates; 90 appropriate-for-gestational age (AGA) neonates served as controls. All pregnancies underwent nuchal translucency (NT) screening at 11-14 weeks' gestation. Pregnancies were dated by accurate last menstrual period consistent with crown-rump length (CRL) measurements at the time of screening, early pregnancy CRL or date of fertilization. The association between birth weight and the difference between the measured and the expected CRL at the time of NT screening was analyzed.
RESULTS: The difference between measured and expected CRL, expressed both in mm and in days of gestation, was statistically greater in the severely macrosomic neonates compared with controls (mean, 6.66 +/- 4.78 mm vs. 1.17 +/- 4.6 mm, P < 0.0001 and 3 +/- 2.2 days vs. 0.5 +/- 2.3 days, P < 0.0001, respectively). Furthermore, there were significant correlations between the extent of macrosomia and the discrepancy between expected and measured fetal size at the time of NT screening (r = 0.47, P < 0.01 and r = 0.48, P < 0.01, respectively).
CONCLUSION: Severe macrosomia apparently manifests as early as 11-14 weeks' gestation. (c) 2008 ISUOG. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2008        PMID: 18570208     DOI: 10.1002/uog.5310

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN: 0960-7692            Impact factor:   7.299


  2 in total

Review 1.  Sonographic evaluation and the pregnancy complicated by diabetes.

Authors:  Jennifer M McNamara; Anthony O Odibo
Journal:  Curr Diab Rep       Date:  2011-02       Impact factor: 4.810

2.  The Impact of Neighbourhood Deprivation on Embryonic Growth Trajectories: Rotterdam Periconception Cohort.

Authors:  Dionne V Gootjes; Maria P H Koster; Sten P Willemsen; Anton H J Koning; Eric A P Steegers; Régine P M Steegers-Theunissen
Journal:  J Clin Med       Date:  2019-11-08       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.